Cryopreservation of a Whole Ovary As a Strategy for Restoring Ovarian Function

od Imhof, M., Hofstetter, G., Bergmeister, H., Rudas, M., Kain, R., Lipovac, M., Huber, J.
Wydane 2004

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-α and retinoids

od Brodowicz, T, Wiltschke, C, Kandioler-Eckersberger, D, Grunt, T W, Rudas, M, Schneider, S M, Hejna, M, Budinsky, A, Zielinski, C C
Wydane 1999

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

od Fiegl, M., Tueni, C., Schenk, T., Jakesz, R., Gnant, M., Reiner, A., Rudas, M., Pirc-Danoewinata, H., Marosi, C., Huber, H.
Wydane 1995

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status

od Brodowicz, T, Kandioler, D, Tomek, S, Ludwig, C, Rudas, M, Kunstfeld, R, Koestler, W, Hejna, M, Budinsky, A, Wiltschke, C, Zielinski, C C
Wydane 2001

P08.01 RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)

od Berghoff, A.S., Bartsch, R., Bergen, E., Rudas, M., Gnant, M., Dieckmann, K., Pinker, K., Zielinski, C.C., Steger, G.G., Preusser, M.
Wydane 2014

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer...

od Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M
Wydane w Br J Cancer (2015)

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer

od Exner, R, Bago-Horvath, Z, Bartsch, R, Mittlboeck, M, Retèl, V P, Fitzal, F, Rudas, M, Singer, C, Pfeiler, G, Gnant, M, Jakesz, R, Dubsky, P
Wydane 2014

Prognostic impact of breast cancer subtypes in elderly patients

od Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Wydane w Breast Cancer Res Treat (2016)

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

od Bartsch, R, Berghoff, A, Pluschnig, U, Bago-Horvath, Z, Dubsky, P, Rottenfusser, A, DeVries, C, Rudas, M, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G
Wydane 2012

A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort

od Dubsky, P., Van't Veer, L., Gnant, M., Rudas, M., Bago-Horvath, Z., Greil, R., Lujinovic, E., Buresch, J., Rinnerthaler, G., Hulla, W., Moinfar, F., Egle, D., Herz, W., Dreezen, C., Frantal, S., Filipits, M.
Wydane w ESMO Open (2020)

Brain metastases free survival differs between breast cancer subtypes

od Berghoff, A, Bago-Horvath, Z, De Vries, C, Dubsky, P, Pluschnig, U, Rudas, M, Rottenfusser, A, Knauer, M, Eiter, H, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G, Preusser, M, Bartsch, R
Wydane 2012

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

od Dubsky, P., Filipits, M., Jakesz, R., Rudas, M., Singer, C. F., Greil, R., Dietze, O., Luisser, I., Klug, E., Sedivy, R., Bachner, M., Mayr, D., Schmidt, M., Gehrmann, M. C., Petry, C., Weber, K. E., Kronenwett, R., Brase, J. C., Gnant, M.
Wydane 2013

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

od Dubsky, P, Brase, J C, Jakesz, R, Rudas, M, Singer, C F, Greil, R, Dietze, O, Luisser, I, Klug, E, Sedivy, R, Bachner, M, Mayr, D, Schmidt, M, Gehrmann, M C, Petry, C, Weber, K E, Fisch, K, Kronenwett, R, Gnant, M, Filipits, M
Wydane 2013